Trial intelligence / Profile preview

Effect of Prophylactic Intravenous Ondansetron on Maternal Hypotension and Bradycardia During Spinal Anesthesia for Cesarean Section

NCT07883772Completed

Sponsor
Aydın Adnan Menderes University
Start
Apr 2021
Primary completion
Apr 2022
Countries
1
01

Overview

Randomised, double-blind trial of ondansetron in hypotension and bradycardia, sponsored by Aydın Adnan Menderes University. Primary endpoint: Incidence of maternal hypotension. Started Apr 2021; status: completed.

02

Drugs

ondansetron
03

Conditions

hypotensionbradycardia

Beyond the preview

Go deeper on NCT07883772.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07883772.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call